Mayland announced abnormal fluctuations in stock trading. Up to now, the company's products in the field of brain-computer interface are still in the R&D and market development period, have not achieved large-scale sales, and have yet to have a significant impact on the company's performance. In terms of technology, the company mainly focuses on the development and commercialization of non-intrusive brain-computer interface technology, and there is a significant technical path difference with the current mainstream international intrusive brain-computer interface.

Mayland announced abnormal fluctuations in stock trading. Up to now, the company's products in the field of brain-computer interface are still in the R&D and market development period, have not achieved large-scale sales, and have yet to have a significant impact on the company's performance. In terms of technology, the company mainly focuses on the development and commercialization of non-intrusive brain-computer interface technology, and there is a significant technical path difference with the current mainstream international intrusive brain-computer interface.